Jun Liu

and 4 more

Background: This study aims to preliminarily explore the impact of delayed influenza virus nucleic acid conversion (more than five days) to negative on treatment and length of hospital stay in children with severe influenza. Methods: This was a single-center retrospective study. General information, influenza virus nucleic acid test (per 3-5 days) results after receiving antiviral medication, antiviral drug usage, comorbid infections, invasive mechanical ventilation, and discharge prognosis of children with severe influenza were collected. Results: A total of 39 patients were included in the study. The patients were divided into four groups based on the time when the patient’s viral nucleic acid turned to negative after receiving antiviral medication: 3-5 days (35.8%, 14/39), 6-10 days (38.4%, 15/39), >10 days (12.8%, 5/39), and maintaining as positive when discharge (12.8%, 5/39). More than half of pediatric patients with severe influenza exhibited delayed nucleic acid conversion (more than 5 days) after antiviral medication. The >10 days group had a longer time from onset to PICU admission, PICU stay, and antiviral drug use duration, as well as a higher proportion of CBP use (P < 0.05, respectively). Within the first 3 days of PICU admission, the proportion of patients with persistently reduced lymphocytes was lower in the 3-5 days group (28.6% (4/14)) than other two groups (P > 0.05). Conclusions: Delayed nucleic acid conversion was associated with longer PICU length of stay. Persistent fever, co-infections, and impaired cellular immune function may contribute to the delay.

Boliang Fang

and 5 more